60 completed, 31 recruiting, 25 unknown, 22 terminated. 166 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 166 | Completed 60, Recruiting 31, Unknown 25, Terminated 22, Not yet recruiting 10, Active not recruiting 9, Withdrawn 9 |
Follow Lymphoma, B-Cell: new trials by email Literature Review of Lymphoma, B-Cell trials Research Report on Lymphoma, B-Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunomonitoring and Predictive Biomarkers After CAR-T Cell Therapy in B-Cell Lymphoma and Multiple Myeloma Biological sample collection and immunomonitoring - B Cell Lymphoma, Multiple Mieloma | Not applicable | Not yet recruiting | Centre Henri Becquerel | 45 | 2026-09-18 | 2026-10-01 |
| This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R ARI-0001 T cells with anti-CD19 chimeric antigen receptor (CAR-T) - Adult B-cell Acute Lymphoblastic Leukemia, Follicular Lymphoma (FL) | Not applicable | Not yet recruiting | GUSTAVO SALGUERO | 12 | 2026-09-01 | 2026-02-17 |
| R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma Penpulimab, Rituximab, Methotrexate - Primary Central Nervous System Lymphoma, Diffuse Large B-Cell Lymphoma | Not applicable | Not yet recruiting | WEI XU | 58 | 2026-08-01 | 2026-08-14 |
| Connected Blood Pressure Monitoring in Patients With Hematologic Malignancies Initiating Covalent BTK Inhibitors Connected home blood pressure monitoring with daily IPA supervision. - Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma ( FL) | Not applicable | Not yet recruiting | Centre Hospitalier de la côte Basque | 40 | 2026-07-01 | 2026-06-22 |
| Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma Oral Antiretroviral Therapy, albuvirtide, Cabotegravir/Rilpivirine - AIDS-related Lymphoma, HIV Infection | Not applicable | Recruiting | Shanghai Public Health Clinical Center | 60 | 2026-05-26 | 2026-07-27 |
| Geriatric-guided Care Versus Conventional Care in Elderly Unfit/Frail Patients With Diffuse Large B-cell Lymphoma in First Line Treatment Geriatric-guided supportive care, Conventional supportive care - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3B | Not applicable | Not yet recruiting | Fondazione Italiana Linfomi - ETS | 170 | 2026-05-01 | 2026-04-15 |
| Proton Therapy for Mediastinal Lymphoma (PROMLY) Proton therapy - Mediastinal Lymphoma, Hodgkin Disease Lymphoma | Not applicable | Recruiting | Copenhagen University Hospital, Rigshospitalet | 139 | 2026-05-01 | 2026-09-14 |
| A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma Biospecimen Collection, Cognitive Intervention, Electronic Health Record Review - Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Multiple Myeloma | Not applicable | Recruiting | Ohio State University Comprehensive Cancer Center | 90 | 2026-04-28 | 2026-05-27 |
| Anti CD19 Gene Therapy for B-cell Lymphoma Anti-CD19 gene injection - B-cell Lymphoma | Not applicable | Recruiting | Anhui Provincial Hospital | 18 | 2026-03-20 | 2026-01-21 |
| A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies MTM-H-001 Injection - Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Follicular | Not applicable | Not yet recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 69 | 2026-03-01 | 2026-03-17 |
| Zanubrutinib, Rituximab, and Lenalidomide in the First-Line Treatment of Marginal Zone Lymphoma Zanubrutinib, Rituximab, and Lenalidomide as first-line treatment for Marginal Zone Lymphoma, Zanubrutinib, Rituximab, and Lenalidomide as the primary treatment for Marginal Zone Lymphoma - Marginal Zone Lymphoma(MZL) | Not applicable | Not yet recruiting | Zhengzhou University | 50 | 2026-01-01 | 2025-12-23 |
| Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma AcNK-Sup003 cell injection - R/R B-NHL, Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (R/R B-NHL) | Not applicable | Not yet recruiting | Donghua Zhang | 28 | 2025-12-31 | 2026-01-16 |
| Hyperfractionated Dual Equivalent Fractionated Radiation Therapy Bridging Radiation Therapy - Diffuse Large B-Cell Lymphoma | Not applicable | Recruiting | Yale University | 10 | 2025-10-30 | 2026-06-22 |
| Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia Activity Tracking, Biospecimen Collection, Cognitive Assessment - Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia | Not applicable | Recruiting | University of Washington | 50 | 2025-10-15 | 2026-08-19 |
| CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma chimeric antigen receptor gene modified T cells - Lymphoma, B-Cell | Not applicable | Recruiting | Shanxi Bethune Hospital | 15 | 2025-09-05 | 2025-02-27 |
| Combating Cancer-Related Fatigue: A Personalized Supportive Care Program Exercise, Diet - Indolent Lymphomas, Lymphoma | Not applicable | Recruiting | UNC Lineberger Comprehensive Cancer Center | 40 | 2025-06-03 | 2026-07-01 |
| JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia JY231 Injection - B Acute Lymphoblastic Leukemia, B-Non Hodgkin Lymphoma | Not applicable | Recruiting | Affiliated Hospital of Guangdong Medical University | 20 | 2025-05-30 | 2025-06-10 |
| Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL) Nutrition Intervention, Exercise intervention - Philadelphia Chromosome Negative, B Cell Acute Lymphoblastic Leukemia (B-ALL) | Not applicable | Recruiting | University of Chicago | 20 | 2025-05-12 | 2025-06-19 |
| Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis - Lymphoblastic Leukemia, Relapsed or Refractory Multiple Myeloma (RRMM) | Not applicable | Recruiting | Anhui Provincial Hospital | 18 | 2025-04-16 | 2025-05-29 |
| JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia JY231 Injection - B Acute Lymphoblastic Leukemia, B-Non Hodgkin Lymphoma | Not applicable | Recruiting | Shenzhen Genocury Biotech Co., Ltd. | 20 | 2025-03-01 | 2025-05-15 |
Showing 20 of 166. Sign in to see all of them.
Lymphoma, Large B-Cell, Diffuse (111) · Burkitt Lymphoma (70) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (68) · Lymphoma, Follicular (67) · Leukemia, Lymphocytic, Chronic, B-Cell (61) · Lymphoma, B-Cell, Marginal Zone (59) · Lymphoma, Mantle-Cell (59) · Lymphoma (58) · Lymphoma, Non-Hodgkin (55) · Hodgkin Disease (51) · Multiple Myeloma (50) · Lymphoma, Large-Cell, Immunoblastic (47) · Leukemia, Myeloid, Acute (43) · Lymphoma, T-Cell, Cutaneous (43) · Mycosis Fungoides (39)
Hemic and Lymphatic Diseases (166) · Immune System Diseases (165) · Immunoproliferative Disorders (165) · Lymphatic Diseases (165) · Neoplasms by Histologic Type (165) · Lymphoproliferative Disorders (161) · Neoplasms (153) · Lymphoma, Non-Hodgkin (111) · Lymphoma (108) · Hematologic Diseases (88) · Pathological Conditions, Signs and Symptoms (84) · Leukemia, Lymphoid (83) · Pathologic Processes (78) · Disease Attributes (74)
Cyclophosphamide (21) · Rituximab (16) · fludarabine phosphate (16) · Peripheral Blood Stem Cell Transplantation (14) · Cyclosporine (13) · Filgrastim (13) · Whole-Body Irradiation (10) · Mycophenolic Acid (9) · Antilymphocyte Serum (8) · Radiotherapy (8) · Busulfan (7) · Melphalan (7) · Methotrexate (7) · Prednisone (7) · Etoposide (6)
Fred Hutchinson Cancer Center (9) · Centre Henri Becquerel (5) · City of Hope Medical Center (5) · Roswell Park Cancer Institute (5) · Masonic Cancer Center, University of Minnesota (4) · Ohio State University Comprehensive Cancer Center (4) · University of California, San Francisco (4) · Wake Forest University Health Sciences (4) · Case Comprehensive Cancer Center (3) · Duke University (3) · M.D. Anderson Cancer Center (3) · Memorial Sloan Kettering Cancer Center (3) · National Cancer Institute (NCI) (3) · The First Affiliated Hospital of Soochow University (3) · The First Affiliated Hospital with Nanjing Medical University (3)
United States (75) · China (32) · France (18) · Italy (8) · Canada (6) · Germany (6) · South Korea (4) · United Kingdom (3) · Denmark (2) · Israel (2) · Switzerland (2) · Taiwan (2) · Australia (1) · Austria (1) · Belgium (1)
Ann Woolfrey (2) · Charles A. Linker, MD (2) · Christopher Kelsey, MD (2) · Claudio Brunstein, MD (2) · David Maloney (2) · Michael J. Fisch, MD, MPH, FACP (2) · Paul Martin (2) · Philip L. McCarthy, MD (2) · Philip McCarthy (2) · Wei Xu, PhD& MD (2) · Xuejuan Wang, MD (2) · Alessandro Flavio Ferri (1) · Andrea Kuhnl (1) · Andreas Puespoek, m (1) · Anna Halpern, MD (1)
PMID 32499241, PMID 12525530, PMID 15466923, PMID 16174856, PMID 18698002, PMID 18794865, PMID 21715313, PMID 21719601, PMID 22504933, PMID 23358983, PMID 26071053, PMID 26150440, PMID 26451310, PMID 26487230, PMID 28302137, PMID 28817727, PMID 29599530, PMID 32196557, PMID 32223740, PMID 34935483, PMID 35468680, PMID 35530320, PMID 36045296, PMID 37114393, PMID 37192741, PMID 37251628, PMID 37964424, PMID 38160047, PMID 38427337, PMID 39606939, PMID 39620223, PMID 39747123, PMID 40178467, PMID 40598473, PMID 41429707, PMID 41894682, PMID 42426809, PMID 9849691
P30CA015704 (5), P30CA033572 (5), P30CA043703 (3), P01CA018029 (2), P30CA022453 (2), 2017 (1), P01CA015396 (1), P30CA006973 (1), P30CA015083 (1), P30CA016056 (1), P30CA016672 (1), P30CA072720 (1), P50CA097274 (1), R01AI058148 (1), R01CA085748 (1)